Get started
Author

Nadja Auerbach

Institution: Menwell Limited
Observed institution: Menwell Limited
ORCID: 0009-0006-8583-0792
Observed ORCID: 0009-0006-8583-0792
OpenAlex ID: A5115628293
What are community perspectives and experiences around GLP-1 receptor agonist medications for weight loss? A cross-sectional survey study in the UK
2025 · Nadja Auerbach, Vivian N Liu, et al. · BMJ Public Health · 29
PDF
Trends in blood-based metabolic and cardiovascular risk profiles in men during treatment for testosterone deficiency: a longitudinal, retrospective cohort study
2025 · Ashley Kieran Clift, David R Huang, et al. · The Journal of Sexual Medicine
Tirzepatide in the NHS : The known unknowns of treating obesity at a national scale
2025 · Ashley Kieran Clift, Nadja Auerbach, et al. · Diabetes Obesity and Metabolism
PDF
Author response for "Tirzepatide in the NHS : The known unknowns of treating obesity at a national scale"
2025 · Ashley Kieran Clift, Nadja Auerbach, et al. · Publons reviews and discussion
Works count: 4
Citation count: 29
H-index: 1
I10-index: 1
Year
Topic
Type